secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2025-01-22T23:59:59+00:00
Accession:  0001104659-25-005075
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics promotes Behrad Derakhshan to COO
-------------------------------------------------------

- Behrad Derakhshan, Ph.D., appointed Chief Operating Officer effective January 8, 2025.
- Previously served as Chief Business Officer since September 2020.
- Annual base salary increased from $478,400 to $520,000; target bonus raised to 45%.
- No family relationships with any director or executive officer of the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/0001104659-25-005075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465925005075/tm253635d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-005075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer